Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):59–66. doi: 10.1097/QAI.0000000000000226

Table 1.

Study measures and outcomes.

Description Measure Ref.
Sociodemographic /medical information Self-report and medical record NA
Tobacco use and knowledge CDC-QIT 15
Other substance use NIH/NIAID Baseline Substance Use Report 18
Nicotine addiction Modified Fagerstrom Tolerance Questionnaire 19
Motivation to quit Modified Abrams & Biener Readiness to Quit Ladder 20
Self-efficacy Self-efficacy/Temptations Scale 21
Decisional balance Smoking Decisional Balance Short Form 22
Social support Interpersonal Support Evaluation List 23
Loneliness UCLA Loneliness Scale 24
Depression Center for Epidemiologic Studies Depression Scale 25
Anxiety General Anxiety Disorder-7 26
Perceived stress Perceived Stress Scale – 4 Item 27
Study Outcomes
Adherence # of sessions logged into; #web pages visited NA
Engagement # of interactive clicks; # total minutes logged in; NA
Satisfaction* Satisfaction survey designed by study team NA
Study contamination** Questionnaire designed by study team NA
Abstinence (by history) Seven-day point-prevalence abstinence at 3 months 28
Abstinence (biochemical) Exhaled carbon monoxide<10 parts per million*** 29

Note: NA=not applicable, CDC-QIT=Centers for Disease Control-Question Inventory on Tobacco, NIH/NIAID=National Institutes of Health/National Institute of Allergy and Infectious Diseases, UCLA=University of California, Los Angeles

*

PSFW subjects only

**

Standard care subjects only

***

Measured using the Bedfont piCO+ Smokerlyzer (Bedfont Scientific Ltd., Kent, UK) according to manufacturer’s instructions.